It became clear that, in order to fully implement the intent of the streamlining initiative, CSAVR, its member state agencies, and RSA needed to agree on some fundamental changes in policy and practice. To accomplish its goal, the RSA provides its members with leadership and service.
Methadone was introduced into the United States in 1947 by Eli Lilly and Company as an analgesic under the trade name Dolophine, which is now registered to Roxane Laboratories. Since then, it has been best known for its use in treating opioid dependence.
Methadone is a potent narcotic analgesic that is typically prescribed for the purpose of managing severe chronic pain and for the treatment of opioid dependency. Methadone has a cross-tolerance with other opioid drugs, such as heroin and morphine, allowing it to offer similar pain-relieving effects over a longer duration of time. Methadone comes in a variety of strengths and in different appearances, such as in a liquid mixture, tablets, or ampoules for injection.